Regional Resistance Surveillance Program Results for 12 Asia-Pacific Nations (2011)
Author(s) -
Rodrigo E. Mendes,
Myrna Mendoza,
Kirnpal Kaur Banga Singh,
Mariana Castanheira,
Jan M. Bell,
John Turnidge,
Stephen Lin,
Ronald N. Jones
Publication year - 2013
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01121-13
Subject(s) - broth microdilution , amikacin , tigecycline , colistin , microbiology and biotechnology , linezolid , vancomycin , klebsiella pneumoniae , streptococcus pneumoniae , antibiotic resistance , methicillin resistant staphylococcus aureus , drug resistance , staphylococcus aureus , biology , medicine , antimicrobial , antibiotics , minimum inhibitory concentration , escherichia coli , bacteria , biochemistry , genetics , gene
The Regional Resistance Surveillance program monitored susceptibility rates and developing resistance by geographic region, including 12 Asia-Pacific (APAC) countries. Reference broth microdilution methods for susceptibility/interpretations were applied, processing 5,053 strains. Among Staphylococcus aureus isolates (37% methicillin-resistant S. aureus [MRSA], highest in South Korea [73%]), linezolid (LZD), tigecycline (TIG), and vancomycin were 100% active, but 33 and 34% of strains were levofloxacin (LEV) or macrolide resistant, respectively. Streptococcus pneumoniae was most resistant to β-lactams and macrolides (45%) but was LZD, LEV, and TIG susceptible (>98%). Extended-spectrum β-lactamase (ESBL) phenotype rates in Escherichia coli and Klebsiella spp. were 48 and 47%, respectively, and were highest in Taiwan, at 75 to 91%. The best anti-ESBL-phenotype agents were amikacin (81 to 96% susceptible), colistin (COL; >98%), TIG (>98%), and carbapenems (81 to 97%). Pseudomonas aeruginosa showed ≥20% resistance to all drugs except COL (99% susceptible). In conclusion, endemic evolving antimicrobial resistances in APAC nations show compromised roles for many commonly used antimicrobials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom